• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单胺氧化酶抑制剂的不良反应。第二部分。治疗相关性及临床管理。

Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management.

作者信息

Rabkin J G, Quitkin F M, McGrath P, Harrison W, Tricamo E

出版信息

J Clin Psychopharmacol. 1985 Feb;5(1):2-9.

PMID:3973068
Abstract

From a review of the clinical charts of 198 depressed outpatients, information was extracted on common major treatment emergent side effects associated with phenelzine, tranylcypromine, and imipramine. These included hypertensive reactions, severe orthostatic hypotension, hypomania, significant weight gain, sexual dysfunction, and a residual category of multiple side effects which together culminated in drug discontinuation. In this report, frequency of their occurrence for each drug, level of severity, relation to dose and treatment duration, and physician response at the time the side effect was recorded are described. In addition, procedures found useful in the clinical management of these side effects are discussed.

摘要

通过回顾198例门诊抑郁症患者的临床病历,提取了与苯乙肼、反苯环丙胺和丙咪嗪相关的常见主要治疗中出现的副作用信息。这些副作用包括高血压反应、严重直立性低血压、轻躁狂、显著体重增加、性功能障碍以及导致停药的多种副作用的残余类别。在本报告中,描述了每种药物副作用的发生频率、严重程度、与剂量和治疗持续时间的关系以及记录副作用时医生的应对措施。此外,还讨论了在这些副作用临床管理中发现有用的程序。

相似文献

1
Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management.单胺氧化酶抑制剂的不良反应。第二部分。治疗相关性及临床管理。
J Clin Psychopharmacol. 1985 Feb;5(1):2-9.
2
Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study.单胺氧化酶抑制剂的不良反应。第一部分。一项对比研究。
J Clin Psychopharmacol. 1984 Oct;4(5):270-8.
3
Monoamine oxidase inhibitors.单胺氧化酶抑制剂
Am Fam Physician. 1986 Jul;34(1):113-9.
4
Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.苯乙肼和反苯环丙胺对难治性抑郁症直立性应激的持续影响。
J Clin Psychopharmacol. 2006 Oct;26(5):542-4. doi: 10.1097/01.jcp.0000236657.08663.ae.
5
[Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].[经典单胺氧化酶抑制剂:未注册用于治疗抑郁症,但在抑郁症治疗中仍占有一席之地]
Ned Tijdschr Geneeskd. 2003 Oct 4;147(40):1940-3.
6
'Spontaneous' hypertensive episodes with monoamine oxidase inhibitors.单胺氧化酶抑制剂引发的“自发性”高血压发作。
J Clin Psychiatry. 1988 Apr;49(4):163-5.
7
[Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].[单胺氧化酶(MAOI)抑制剂作为抗抑郁药物的滥用:批判性综述]
Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1995 Jul-Aug;23(4):217-22.
8
Common side effects associated with monoamine oxidase inhibitors.与单胺氧化酶抑制剂相关的常见副作用。
Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(3-4):497-504. doi: 10.1016/0278-5846(89)90137-1.
9
Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.在单胺氧化酶抑制剂中添加L-色氨酸后出现两例轻躁狂症。
Am J Psychiatry. 1985 Dec;142(12):1487-8. doi: 10.1176/ajp.142.12.1487.
10
Refractory depression treated with high doses of monoamine oxidase inhibitor.
J Clin Psychiatry. 1987 Jan;48(1):31-2.

引用本文的文献

1
Weight-centric treatment of depression and chronic pain.以体重为中心治疗抑郁症和慢性疼痛。
Obes Pillars. 2022 Jun 23;3:100025. doi: 10.1016/j.obpill.2022.100025. eCollection 2022 Sep.
2
Antidepressant Drugs Effects on Blood Pressure.抗抑郁药物对血压的影响。
Front Cardiovasc Med. 2021 Aug 3;8:704281. doi: 10.3389/fcvm.2021.704281. eCollection 2021.
3
The trace amine theory of spontaneous hypertension as induced by classic monoamine oxidase inhibitors.经典单胺氧化酶抑制剂诱导自发性高血压的痕量胺理论。
J Neural Transm (Vienna). 2021 Nov;128(11):1741-1756. doi: 10.1007/s00702-021-02399-9. Epub 2021 Aug 9.
4
Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively.精神科实践中的单胺氧化酶抑制剂(MAOIs):如何安全有效地使用它们。
CNS Drugs. 2021 Jul;35(7):703-716. doi: 10.1007/s40263-021-00832-x. Epub 2021 Jul 9.
5
A Review of Antidepressant-Associated Hypomania in Those Diagnosed with Unipolar Depression-Risk Factors, Conceptual Models, and Management.单相抑郁障碍患者抗抑郁药相关轻躁狂的研究述评——风险因素、概念模型与管理
Curr Psychiatry Rep. 2020 Mar 26;22(4):20. doi: 10.1007/s11920-020-01143-6.
6
Natural Antioxidant Anthocyanins-A Hidden Therapeutic Candidate in Metabolic Disorders with Major Focus in Neurodegeneration.天然抗氧化剂花色苷——代谢紊乱治疗的隐藏候选药物,主要关注神经退行性变。
Nutrients. 2019 May 28;11(6):1195. doi: 10.3390/nu11061195.
7
A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths.重新评估单胺氧化酶抑制剂的安全性概况:阐明陈旧的酪胺神话。
J Neural Transm (Vienna). 2018 Nov;125(11):1707-1717. doi: 10.1007/s00702-018-1932-y. Epub 2018 Sep 25.
8
Medications that cause weight gain and alternatives in Canada: a narrative review.加拿大导致体重增加的药物及其替代药物:一项叙述性综述
Diabetes Metab Syndr Obes. 2018 Aug 21;11:427-438. doi: 10.2147/DMSO.S171365. eCollection 2018.
9
Monoamine oxidase inhibitors: clinical review.单胺氧化酶抑制剂:临床综述。
Can Fam Physician. 1990 Jun;36:1151-5.
10
Brofaromine--a review of its pharmacological properties and therapeutic use.溴法罗明——其药理特性与治疗用途综述
J Neural Transm (Vienna). 1996;103(1-2):217-45. doi: 10.1007/BF01292628.